These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26822284)

  • 1. Fragment-Based Protein-Protein Interaction Antagonists of a Viral Dimeric Protease.
    Gable JE; Lee GM; Acker TM; Hulce KR; Gonzalez ER; Schweigler P; Melkko S; Farady CJ; Craik CS
    ChemMedChem; 2016 Apr; 11(8):862-9. PubMed ID: 26822284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpesvirus protease inhibition by dimer disruption.
    Shimba N; Nomura AM; Marnett AB; Craik CS
    J Virol; 2004 Jun; 78(12):6657-65. PubMed ID: 15163756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum allosteric inhibition of herpesvirus proteases.
    Gable JE; Lee GM; Jaishankar P; Hearn BR; Waddling CA; Renslo AR; Craik CS
    Biochemistry; 2014 Jul; 53(28):4648-60. PubMed ID: 24977643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).
    Unal A; Pray TR; Lagunoff M; Pennington MW; Ganem D; Craik CS
    J Virol; 1997 Sep; 71(9):7030-8. PubMed ID: 9261433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme inhibition by allosteric capture of an inactive conformation.
    Lee GM; Shahian T; Baharuddin A; Gable JE; Craik CS
    J Mol Biol; 2011 Sep; 411(5):999-1016. PubMed ID: 21723875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational change coupling the dimerization and activation of KSHV protease.
    Pray TR; Reiling KK; Demirjian BG; Craik CS
    Biochemistry; 2002 Feb; 41(5):1474-82. PubMed ID: 11814340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease dimer formation disrupted.
    Chmielewski J
    Nat Chem Biol; 2009 Sep; 5(9):607-8. PubMed ID: 19690531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric Inhibitors, Crystallography, and Comparative Analysis Reveal Network of Coordinated Movement across Human Herpesvirus Proteases.
    Acker TM; Gable JE; Bohn MF; Jaishankar P; Thompson MC; Fraser JS; Renslo AR; Craik CS
    J Am Chem Soc; 2017 Aug; 139(34):11650-11653. PubMed ID: 28759216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of a viral enzyme by a small-molecule dimer disruptor.
    Shahian T; Lee GM; Lazic A; Arnold LA; Velusamy P; Roels CM; Guy RK; Craik CS
    Nat Chem Biol; 2009 Sep; 5(9):640-6. PubMed ID: 19633659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional consequences of the Kaposi's sarcoma-associated herpesvirus protease structure: regulation of activity and dimerization by conserved structural elements.
    Reiling KK; Pray TR; Craik CS; Stroud RM
    Biochemistry; 2000 Oct; 39(42):12796-803. PubMed ID: 11041844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approach of fragment-based lead discovery applied to renin inhibitors.
    Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
    Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease.
    Nomura AM; Marnett AB; Shimba N; Dötsch V; Craik CS
    Biochemistry; 2006 Mar; 45(11):3572-9. PubMed ID: 16533039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced structure of a helical switch as a mechanism to regulate enzymatic activity.
    Nomura AM; Marnett AB; Shimba N; Dötsch V; Craik CS
    Nat Struct Mol Biol; 2005 Nov; 12(11):1019-20. PubMed ID: 16244665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A screening strategy for trapping the inactive conformer of a dimeric enzyme with a small molecule inhibitor.
    Craik CS; Shahian T
    Methods Mol Biol; 2012; 928():119-31. PubMed ID: 22956137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auto-inactivation by cleavage within the dimer interface of Kaposi's sarcoma-associated herpesvirus protease.
    Pray TR; Nomura AM; Pennington MW; Craik CS
    J Mol Biol; 1999 Jun; 289(2):197-203. PubMed ID: 10366498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
    Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME
    Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: identification and development of β-secretase (BACE-1) binding fragments and inhibitors by dynamic ligation screening (DLS).
    Fernández-Bachiller MI; Horatscheck A; Lisurek M; Rademann J
    ChemMedChem; 2013 Jul; 8(7):1041-56. PubMed ID: 23757181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The herpesvirus protease: mechanistic studies and discovery of inhibitors of the human cytomegalovirus protease.
    Flynn DL; Becker DP; Dilworth VM; Highkin MK; Hippenmeyer PJ; Houseman KA; Levine LM; Li M; Moormann AE; Rankin A; Toth MV; Villamil CI; Wittwer AJ; Holwerda BC
    Drug Des Discov; 1997 May; 15(1):3-15. PubMed ID: 9332827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of covalent active site inhibitors of dengue virus protease.
    Koh-Stenta X; Joy J; Wang SF; Kwek PZ; Wee JL; Wan KF; Gayen S; Chen AS; Kang C; Lee MA; Poulsen A; Vasudevan SG; Hill J; Nacro K
    Drug Des Devel Ther; 2015; 9():6389-99. PubMed ID: 26677315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
    Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
    Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.